Pet Center Inc.

CLOSEOUT LETTER Pet Center Inc. MARCS-CMS 621716 — March 06, 2023 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED Product: Animal & Veterinary Recipient: Recipient Name Philip Mizrahie Recipient Title President Pet Center Inc. 4105 W. Jefferson Blvd. Los Angeles , CA 90016-4124 United States Issuing Office: Office of Human and Animal Food Operations West Division 5 United States Dear Mr. Mizrahie: The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter #621716 dated February 28, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Darla R. Bracy District Director | FDA San Francisco District Program Division Director Office of Human and Animal Food Operations West Division 5 Content current as of: 03/23/2023 Regulated Product(s) Animal & Veterinary